VULVAR CARCINOMA
Clinical trials for VULVAR CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new VULVAR CARCINOMA trials appear
Sign up with your email to follow new studies for VULVAR CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Major trial aims to tame dozens of rare, neglected cancers with immune power combo
Disease control OngoingThis study is testing whether a combination of two immunotherapy drugs (nivolumab and ipilimumab) can help control many different types of rare, advanced cancers that have limited treatment options. It enrolled over 800 adults whose cancer progressed after standard therapy. The g…
Matched conditions: VULVAR CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 04, 2026 03:21 UTC
-
Major cancer trial tests new hope for patients Who've run out of options
Disease control OngoingThis study tested pembrolizumab, an immunotherapy drug, in people with advanced solid tumors who had already tried standard treatments that stopped working. Researchers enrolled 1,609 participants with various cancers including anal, cervical, lung, and thyroid cancers to see how…
Matched conditions: VULVAR CARCINOMA
Phase: PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Apr 02, 2026 14:58 UTC
-
Tracking life after radical cancer surgery: a Decade-Long look
Knowledge-focused OngoingThis study aims to understand the long-term recovery and quality of life for women who have undergone a major surgery called pelvic exenteration for gynecologic cancers. Researchers are observing 79 women to see how different surgical techniques affect complications, survival, an…
Matched conditions: VULVAR CARCINOMA
Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated Apr 03, 2026 14:42 UTC